137 related articles for article (PubMed ID: 31503175)
1. Developing Texting for Relapse Prevention: A Scalable mHealth Program for People With Schizophrenia and Schizoaffective Disorder.
Ybarra ML; Rodriguez K; Madison H; Mojtabai R; Cullen BA
J Nerv Ment Dis; 2019 Oct; 207(10):854-862. PubMed ID: 31503175
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of Texting 4 Relapse Prevention, Text Messaging-Based Relapse Prevention Program for People With Schizophrenia and Schizoaffective Disorder.
Ybarra ML; Rodriguez KM; Fehmie DA; Mojtabai R; Cullen B
J Nerv Ment Dis; 2022 Feb; 210(2):123-128. PubMed ID: 34570061
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study.
Cullen BA; Rodriguez K; Eaton WW; Mojtabai R; Von Mach T; Ybarra ML
Psychiatry Res; 2020 Oct; 292():113346. PubMed ID: 32750572
[TBL] [Abstract][Full Text] [Related]
4. Psychiatrist's adherence: a new factor in relapse prevention of schizophrenia. A randomized controlled study on relapse control through telemedicine system.
Spaniel F; Novak T; Bankovska Motlova L; Capkova J; Slovakova A; Trancik P; Matejka M; Höschl C
J Psychiatr Ment Health Nurs; 2015 Dec; 22(10):811-20. PubMed ID: 26176646
[TBL] [Abstract][Full Text] [Related]
5. Coordinated Technology-Delivered Treatment to Prevent Rehospitalization in Schizophrenia: A Novel Model of Care.
Brunette MF; Rotondi AJ; Ben-Zeev D; Gottlieb JD; Mueser KT; Robinson DG; Achtyes ED; Gingerich S; Marcy P; Schooler NR; Meyer-Kalos P; Kane JM
Psychiatr Serv; 2016 Apr; 67(4):444-7. PubMed ID: 26725297
[TBL] [Abstract][Full Text] [Related]
6. Development and Long-Term Acceptability of ExPRESS, a Mobile Phone App to Monitor Basic Symptoms and Early Signs of Psychosis Relapse.
Eisner E; Drake RJ; Berry N; Barrowclough C; Emsley R; Machin M; Bucci S
JMIR Mhealth Uhealth; 2019 Mar; 7(3):e11568. PubMed ID: 30924789
[TBL] [Abstract][Full Text] [Related]
7. Schizophrenia prediction with the adaboost algorithm.
Hrdlicka J; Klema J
Stud Health Technol Inform; 2011; 169():574-8. PubMed ID: 21893814
[TBL] [Abstract][Full Text] [Related]
8. Relapse prevention through health technology program reduces hospitalization in schizophrenia.
Homan P; Schooler NR; Brunette MF; Rotondi A; Ben-Zeev D; Gottlieb JD; Mueser KT; Achtyes ED; Gingerich S; Marcy P; Meyer-Kalos P; Hauser M; John M; Robinson DG; Kane JM
Psychol Med; 2023 Jul; 53(9):4114-4120. PubMed ID: 35634965
[TBL] [Abstract][Full Text] [Related]
9. Early intervention in psychotic relapse.
Birchwood M; Spencer E
Clin Psychol Rev; 2001 Nov; 21(8):1211-26. PubMed ID: 11702513
[TBL] [Abstract][Full Text] [Related]
10. Training to recognise the early signs of recurrence in schizophrenia.
Morriss R; Vinjamuri I; Faizal MA; Bolton CA; McCarthy JP
Cochrane Database Syst Rev; 2013 Feb; (2):CD005147. PubMed ID: 23450559
[TBL] [Abstract][Full Text] [Related]
11. Text Messaging for Exercise Promotion in Older Adults From an Upper-Middle-Income Country: Randomized Controlled Trial.
Müller AM; Khoo S; Morris T
J Med Internet Res; 2016 Jan; 18(1):e5. PubMed ID: 26742999
[TBL] [Abstract][Full Text] [Related]
12. Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder.
Fu DJ; Turkoz I; Simonson RB; Walling DP; Schooler NR; Lindenmayer JP; Canuso CM; Alphs L
J Clin Psychiatry; 2015 Mar; 76(3):253-62. PubMed ID: 25562685
[TBL] [Abstract][Full Text] [Related]
13. Iteratively Developing an mHealth HIV Prevention Program for Sexual Minority Adolescent Men.
Ybarra ML; Prescott TL; Philips GL; Bull SS; Parsons JT; Mustanski B
AIDS Behav; 2016 Jun; 20(6):1157-72. PubMed ID: 26238038
[TBL] [Abstract][Full Text] [Related]
14. CrossCheck: Integrating self-report, behavioral sensing, and smartphone use to identify digital indicators of psychotic relapse.
Ben-Zeev D; Brian R; Wang R; Wang W; Campbell AT; Aung MSH; Merrill M; Tseng VWS; Choudhury T; Hauser M; Kane JM; Scherer EA
Psychiatr Rehabil J; 2017 Sep; 40(3):266-275. PubMed ID: 28368138
[TBL] [Abstract][Full Text] [Related]
15. Remote "hovering" with individuals with psychotic disorders and substance use: feasibility, engagement, and therapeutic alliance with a text-messaging mobile interventionist.
Ben-Zeev D; Kaiser SM; Krzos I
J Dual Diagn; 2014; 10(4):197-203. PubMed ID: 25391277
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse.
Beasley CM; Sutton VK; Hamilton SH; Walker DJ; Dossenbach M; Taylor CC; Alaka KJ; Bykowski D; Tollefson GD;
J Clin Psychopharmacol; 2003 Dec; 23(6):582-94. PubMed ID: 14624189
[TBL] [Abstract][Full Text] [Related]
17. Emerging mHealth and eHealth interventions for serious mental illness: a review of the literature.
Naslund JA; Marsch LA; McHugo GJ; Bartels SJ
J Ment Health; 2015; 24(5):321-32. PubMed ID: 26017625
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of using a smartphone app to assess early signs, basic symptoms and psychotic symptoms over six months: A preliminary report.
Eisner E; Bucci S; Berry N; Emsley R; Barrowclough C; Drake RJ
Schizophr Res; 2019 Jun; 208():105-113. PubMed ID: 30979665
[TBL] [Abstract][Full Text] [Related]
19. The impact of thought disorder on therapeutic alliance and personal recovery in schizophrenia and schizoaffective disorder: An exploratory study.
Cavelti M; Homan P; Vauth R
Psychiatry Res; 2016 May; 239():92-8. PubMed ID: 27137967
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and outcomes of a multi-function mobile health approach for the schizophrenia spectrum: App4Independence (A4i).
Kidd SA; Feldcamp L; Adler A; Kaleis L; Wang W; Vichnevetski K; McKenzie K; Voineskos A
PLoS One; 2019; 14(7):e0219491. PubMed ID: 31306439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
